| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 87 | 340 | 1,090 | $70 | $1.4M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 60 | 100 | 1,490 | $70 | $1.3M |
| G0378 | Hospital observation service, per hour | 5 | 130 | 1,270 | $560 | $1.2M |
| 96361 | The provider administers intravenous, or IV, fluids with electrolytes through an already established intravenous route for each additional hour to treat more severe dehydration. | 9 | 210 | 2,850 | $180 | $1.1M |
| 92507 | The provider treats a patient with communication and hearing difficulties by directly interacting with the patient. He assesses the patient with impairment in his ability to make sounds, along with… | 218 | 750 | 1,800 | $80 | $785.8K |
| 99283 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a low level of medical decision making. | 73 | 1,420 | 90 | $130 | $715.2K |
| 99282 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a straightforward level of medical decision making. | 46 | 450 | 370 | $170 | $674.1K |
| C1889 | Implantable/insertable device, not otherwise classified | 17 | 40 | 320 | $260 | $533.3K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 42 | 140 | 360 | $130 | $492.1K |
| 99284 | The provider sees a patient for an emergency department visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making. | 64 | 2,210 | 80 | $130 | $473K |